HOPKINTON, Mass., Feb. 23, 2011 /PRNewswire/ — Caliper Life
Sciences, Inc. (Nasdaq:
CALP) and Covaris Inc., Woburn, Mass., today announced a
co-marketing agreement which will leverage Covaris’ acoustic DNA
shearing platforms and Caliper’s automation and microfluidics
technologies to develop automated workflows for next generation
sequencing experiments. Caliper has developed a complete suite of
solutions for library construction, sample analysis, and nucleic
acid fractionation, which significantly reduces manual
manipulations, increases throughput and improves sample-to-sample
consistency.
“Our Sciclone NGS, LabChip GX, and LabChip XT have become
critical tools in leading next generation sequencing laboratories
already utilizing Covaris’ technology,” said Kevin Hrusovsky,
President and Chief Executive Officer of Caliper Life Sciences.
“This collaboration is a logical next step toward simplifying
workflows for scientists challenged with meeting the growing
demands of next generation sequencing sample preparation. As
sequencing technologies move from the lab bench to the clinic, it
is critical that integrated solutions offer consistency and sample
tracking.”
“Covaris provides a wide variety of next-gen sample prep
solutions for the evolving needs of sequencing laboratories
relative to nucleic acid shearing and sample extraction,” said Jim
Laugharn, Covaris President and Chief Executive Officer.
“Covaris recognizes the importance of high quality sample
preparation as a fundamental component for advanced life science
systems, such as in Next Generation DNA Sequencing.”
Covaris sample preparation technology, which is based on its
industry-standard
